Descrizione del progetto
Sostenere gli studi genomici ed evolutivi in Estonia
I progressi tecnologici nel campo della genomica consentono agli scienziati di ricostruire la storia genetica della nostra specie. Si può fare lo stesso per le malattie comuni? Esse sono conseguenza di forze trainanti di tipo evolutivo? Il progetto cGEM, finanziato dall’UE, intende affrontare tali questioni contribuendo a istituire un centro integrato per la genomica, l’evoluzione e la medicina in Estonia. I ricercatori svilupperanno modelli di previsione del rischio di malattia allo scopo di comprendere la comparsa di malattie comuni in popolazioni diverse. A tal fine saranno impiegate biobanche interne per le popolazioni locali e verranno instaurate collaborazioni internazionali. L’obiettivo finale è quello di tradurre i risultati nella pratica clinica quotidiana.
Obiettivo
The proposed ERA Chair – the Center for Genomics, Evolution and Medicine (cGEM) aims to apply advancements in genomic medicine in an evolutionarily-aware framework to account for different evolutionary pathways of populations which have led to differences in susceptibility to common diseases. This requires the knowledge about the genetic risk factors for diverse ethnic groups and the tools to highlight the underlying genetic predisposition to diseases in complex human populations. For this reason, we will bring together the scientific expertise in three institutions: the Estonian Biocentre (EBC) and the Estonian Genome Center (EGC) which will be consolidated to form the Institute of Genomics at University of Tartu (IGUT) in January 2018, and the Institute of Clinical Medicine (ICM). The synergy between the three scientific hubs will create the research capacity for tackling the abovementioned aim. This capacity will be built to apply a holistic approach to understand the evolutionary driving forces that have led to common diseases; develop disease risk prediction models applicable in different populations, and explore the means for translating these findings into suitable input for everyday clinical practice.
For these purposes we shall estimate the mutation rate across molecular pathways during the evolution, migration and mixing of the human populations, and study the roles of demographic history and local adaptation in the global patterns of mutation processes in humans exploring regional differences in the accumulation of mutations predisposing individuals to common complex diseases.
the cGEM will utilize its international collaborations and in-house biobanks to advance the personalized medicine solutions for admixed populations for predicting risk of certain complex diseases, including metabolic and cardiovascular diseases, and cancers.
Campo scientifico
Parole chiave
Programma(i)
- H2020-EU.4.c. - Establishing ‚ERA Chairs’ Main Programme
Argomento(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-WIDESPREAD-03-2017-ERAChairs
Meccanismo di finanziamento
CSA - Coordination and support actionCoordinatore
51005 Tartu
Estonia